Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
Garabedian
H D
HD
Gold
H K
HK
D001241:Aspirin / Q000627:therapeutic use; D003328:Coronary Thrombosis / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005344:Fibrinopeptide A / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013917:Thrombin / Q000378:metabolism*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D005344:Fibrinopeptide A; D006493:Heparin; D013917:Thrombin; D010959:Tissue Plasminogen Activator; D001241:Aspirin